Detalles de la búsqueda
1.
Clinical Utility of Inflammatory and Nutritious Index as Therapeutic Prediction of Nivolumab plus Ipilimumab in Advanced Non-Small Cell Lung Cancer.
Oncology
; 102(3): 271-282, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37725914
2.
Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel.
Oncology
; 102(1): 30-42, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37598676
3.
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL).
Jpn J Clin Oncol
; 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594880
4.
Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer.
Int J Clin Oncol
; 29(2): 124-133, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38160406
5.
Association of High LAT1 Expression with Poor Prognosis and Recurrence in Colorectal Cancer Patients Treated with Oxaliplatin-Based Adjuvant Chemotherapy.
Int J Mol Sci
; 24(3)2023 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36768934
6.
A Retrospective Study of the Efficacy and Safety of Naldemedine for Treatment of Opioid-Induced Constipation in Patients with Hepatobiliary Pancreatic Cancer.
Medicina (Kaunas)
; 59(3)2023 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36984494
7.
Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.
Invest New Drugs
; 40(5): 1066-1079, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35749041
8.
Post-Progression Survival Highly Influences Overall Survival in Driver Gene Mutation/Translocation Negative or Unknown Type of Non-Small Cell Lung Cancer.
Oncology
; 100(2): 89-100, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34844253
9.
Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1.
BMC Cancer
; 22(1): 1325, 2022 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36528575
10.
Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.
Chemotherapy
; 67(3): 142-151, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35313303
11.
Monitoring of Current Cancer Therapy by Positron Emission Tomography and Possible Role of Radiomics Assessment.
Int J Mol Sci
; 23(16)2022 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36012657
12.
The Relationship between Tumor Development and Sarcoidosis in Aspects of Carcinogenesis before and after the Onset of Sarcoidosis.
Medicina (Kaunas)
; 58(6)2022 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35744031
13.
Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.
Oncology
; 99(9): 562-570, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34237736
14.
A 54 Gy in three fractions of stereotactic body radiotherapy using CyberKnife for T1b-2aN0M0 pathologically confirmed non-small cell lung cancer.
Jpn J Clin Oncol
; 51(12): 1723-1728, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34580722
15.
Efficacy and Safety of Anti-Programed Death-1 Blockade in Previously Treated Large-Cell Neuroendocrine Carcinoma.
Chemotherapy
; 66(3): 65-71, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33827084
16.
Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations.
Medicina (Kaunas)
; 57(5)2021 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34069436
17.
Clinical Effectiveness of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with a Poor Performance Status.
Medicina (Kaunas)
; 57(11)2021 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34833490
18.
Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations.
Medicina (Kaunas)
; 57(9)2021 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34577852
19.
Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma.
Cancer Sci
; 111(6): 1969-1978, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32302443
20.
Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma.
Br J Cancer
; 122(11): 1686-1694, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32238919